Stempoint Capital’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.78M	Buy	+1,203,941	New	+$2.78M	0.89%	33
2024 Q2	–	Sell	-1,087,785	Closed	-$3.12M	–	60
2024 Q1	$3.12M	Buy	+1,087,785	New	+$3.12M	0.83%	33